Since IL-27 can induce PD-L1 expression in different tumor cell types [40], we assessed IL-27’s capability of upregulating PD-L1 expression in human MM cell lines as compared to the sIL-6R/IL-6 chimera. This evidence concerns the gene IL6 and Miyoshi myopathy.